Search results
US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery
Reuters via Yahoo Finance Canada· 6 months agoThe U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022,...
Q4 2023 Spero Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 4 months agoParticipants Michael Wood; Investor Relations; LifeSci Advisors, LLC. Sath Shukla; President and Chief Executive Officer; Spero Therapeutics Inc Kamal Hamed; Chief Medical Officer; Spero Therapeutics ...